OIS@AAO 2015
LacriScience is in late stage development of its LacriPen, a portable instrument using gold plated single-use sensors that measures osmolarity to +/- 2 mOSM/L and…
Read MoreMegan Baldwin, PhD, Managing Director and CEO of Opthea, gives an update on OPT-302, a soluble receptor consisting of the first three extracellular domains of…
Read MoreAmar Sawhney, PhD, Chairman, Chairman, President & CEO of Ocular Therapeutics, touts the performance of Dextenza, the company’s anti-allergy medication. Instead of taking one drop…
Read MoreBarry Cheskin, co-founder, president, and CEO of PowerVision, introduces the company’s next iteration, Fluidvision 2020, a new IOL that doubles the power of accommodation for…
Read MoreBernhard Gunther, CEO of Novaliq GmbH, delivers an update on the progress of his compay’s drug delivery pipeline. Novaliq develops innovative pharmaceutical formulations based on…
Read MoreChris Pulling, CEO of MicroOptx, tells OISTV about its Brown Glaucoma Implant (new name pending). The implant is used to lower IOP by draining aqueous…
Read MoreYariv Bar-On, CEO of Orca Surgical, explains how his company is trying to change how surgeons remove the corneal epithelium during ophthalmic laser surgery. Orca…
Read MoreAcufocus’ Nick Tarantino, Chief Global Clinical Research & Regulatory Affairs Officer, explains how AcuFocus is taking a “nice and measured” approach to rolling out its…
Read MoreReza Zadno, PhD, EIR at InterWest Partners explains his new role at the Novartis Venture Fund. He’ll advise the pharma company on where to commit…
Read MoreElisabet “Eli” de los Pinos founded Aura Biosciences in 2009 to chase down innovative treatments for cancer. AURA, which made its first presentation at OIS…
Read MoreMichael Ackermann, CEO of start-up Oculeve, gives an update on his work with Allergan following the purchase of his company and its Dry Eye device.…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.